S&P assigns ‘AA/A-1+’ rating to Sentara Healthcare’s bonds

Standard & Poor’s Ratings Services has assigned an “AA/A-1+” rating to Norfolk, Va.-based Sentara Healthcare’s $98.84 million of series 2016A bonds and $98.84 million of series 2016B bonds.

Advertisement

“The rating reflects Sentara’s excellent enterprise profile that has gradually improved through growth and acquisitions,” said S&P credit analyst Martin Arrick. “In addition, the rating reflects Sentara’s excellent and very stable and consistent financial profile.”

The outlook is stable, reflecting S&P’s view that Sentara’s excellent enterprise and financial profiles provide stability at the current rating level.

More articles on healthcare finance:
Medicaid expansion causes Louisiana budget shortfall to shrink
Financial updates from 5 health systems
Hawaii hospital could close within months without additional funding

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.